πŸ‡ΊπŸ‡Έ FDA
Patent

US 7087411

Fusion protein capable of binding VEGF

granted A61KA61K38/00A61P

Quick answer

US patent 7087411 (Fusion protein capable of binding VEGF) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 08 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61P, A61P27/00, A61P27/02